No ESKAPE! New drugs against MRSA, other superbugs still lacking EurekAlert (press release), DC - Some physicians are treating vancomycin-resistant E. faecium with the new antibiotics linezolid, daptomycin, and tigecycline, but these drugs have not been ...
Why antibiotics aren't always the answer WKOW-TV.com, WI - Doctors say the new test may help stop outbreaks by identifying the type of respiratory infection spreading through the community. Labs that have the RVP ...
Bacteria as Art Ivanhoe Broadcast News, FL - He's fighting a new generation of bacterial infections that includes MRSA, a flesh-eating disease resistant to antibiotics. "We thought we had a whole ...
Hospital infections spread, so do lawsuits Wisconsin Law Journal, Wisconsin - by Sylvia Hsieh Boston ? A new type of med-mal lawsuit is on the increase ? claims based on hospital infections. On Nov. 6, a jury awarded $13.5 million to ...
New weapon against man's oldest enemy Pocono Record, PA - Nov 29, 2008 Alberto Cardelle, a professor of public health at ESU, agreed that the lack of research in new antibiotics and antimicrobials was "dismal," and said ...
New orthopedic device spares some from amputation Colorado Springs Gazette, CO - The procedure cost at least $20000, but consider: No one specialist would have been capable of performing the job alone. And the doctors were aided by new...
The Dixie Group Reports Second Quarter 2008 Results MarketWatch - Additional repurchases of the Company's Common Stock may be made based on management's review of developing economic conditions and other opportunities. ...DXYN
Stocks: Where Are the Buyers? BusinessWeek - In August 1990, the ratio bottomed at 0.21, and then consistently showed more and more strength into February 1991. At the bottom in 1982, the ratio jumped ...
Salix Pharmaceuticals Reports 2Q2008 Results FOXBusiness - Aug 4, 2008 "On May 16, 2008 the US Food and Drug Administration informed the Company that it considered the balsalazide tablet New Drug Application to be approvable. ...SLXP
EPL Announces Second Quarter 2008 Results StreetInsider.com (subscription), MI - Revenue for the second quarter of 2008 rose to $125.7 million, representing a new record high for the Company. This was an increase over the prior record ...EPL - NBL
UDR Announces Second Quarter 2008 Results WELT ONLINE, Germany - Island Square is a new mixed-use community located on Mercer Island, minutes from both downtown Seattle and Bellevue. Almaden Lake Village is adjacent to ...UDR
Source: Google News
Observation of the Top Quark - … Marshall, MI Martin, M Marx, B May, AA Mayorov, R … - Physical Review Letters, 1995 - APS ... 16 MI Martin,'12 M. Marx ,38 B. May,29 AA ... boson [4]. In the present Letter, we report new results from ... 0.08 0.36 ? 0.07 0.20 ? 0.05 (N) 1.36 0.21 1.04 0.19 ...
Definition of ?Inductive? Substituent Constants M Charton - The Journal of Organic Chemistry, 1964 - pubs.acs.org ... First, only one measurement suffices to define a new value of ul; second, the pKa
values may be more reliably and reproducibly deter- mined; third, the ...
A new method for estimating karyotype asymmetry - CR Zarco - Taxon, 1986 - JSTOR ... A1 values (0.18-0.22) andAvenula higher A1 values (0.21-0.34 ... shows clearly the enhanced
precision of the new method in ... It may be even more useful when taxa with ...
Searching for new physics in nonleptonic B decays - R Fleischer, J Matias - Physical Review D, 2000 - APS ... the strategies proposed in 4,12 , which may well lead ... presence of large FSI effects,
0.15 (rc 0.21, q 0.63). ... described by 074004-2 SEARCHING FOR NEW PHYSICS IN ...
New Nuclidic Mass Relationship - GT Garvey, I Kelson - Physical Review Letters, 1966 - APS ... Gerald T. Garvey and Itzhak Kelson Yale University, New Haven, Connecticut ... (2) to
work in certain cases may also be ... 6 -0.01 7 0.52 8 -0.10 9 0.21 ? 0.08 10 ...
Scientists discover antibiotic to fight hospital infection
Scientists have discovered a new antibiotic which they say may fight two dangerous germs that bedevil hospitals.
Stephen Soisson, a senior scientist at Merck Research Laboratories and his colleagues looked at 250,000 extracts from natural products, including samples of soil and leaf debris from around the world, the health portal HealthDay News said.
They discovered the antibiotic in South African soil, which they say could fight staph an infection known as methicillin-resistant Staphylococcus aureus (MRSA) that can cause pneumonia in hospital settings and skin infections in the general population.
It may also fight another infection named as Vancomycin-resistant Enterococcus (VRE) that live in the digestive and genital tracts and people infected often need prolonged treatment, usually with several antibiotics being given together by injection.
The researchers tested their antibiotic known as platensimycin derived from a substance found in the soil released by mice and found that it vanquished both MRSA and VRE.
Apparently, the antibiotic works by disrupting the way cells synthesise crucial fatty acids, the scientists said in their work that appeared in the May 18 issue of Nature.
